FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to cardiology, and concerns treating of myocardial infarction (MI). That is ensured by primary transcutaneous transluminal coronary angioplasty with underlying standard conservative therapy is followed with myocardial unload with beta-blocker Carvedilol. Said myocardial unload is combined with introduction of Levosimendan at first administered as a bonus intravenously at 16 mcg/kg during 10 min, and then in stable AP it is infused intravenously within 20-38 hours in total dose 12.5 mg/kg at the rate 0.05 to 0.2 mcg/kg/minutes.
EFFECT: method provides higher survival rate and ensured clinical compensation in the MI patients of elderly and senile age with cardiac failure complications due to combination of endovascular revascularisation and myocardial unload with underlying introduction of inotropic stimulator Levosimendan in the developed doses and regimen.
2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR INDIVIDUAL SELECTION OF SUPPORTING DOSE OF LEVOSIMENDAN FOR TREATING ACUTE HEART FAILURE IN ELDERLY PATIENTS IN ACUTE PHASE OF MYOCARDIAL INFARCTION | 2015 |
|
RU2601666C1 |
| METHOD FOR PREDICTION OF LETHAL OUTCOME IN PATIENTS WITH CARDIOGENIC SHOCK IN PERCUTANEOUS CORONARY INTERVENTION | 2015 |
|
RU2580164C1 |
| METHOD FOR OPTIMIZING PERIOPERATIVE PERIOD OF ELDERLY AND SENILE PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN SURGICAL TREATMENT OF LUNG CANCER | 2020 |
|
RU2757580C1 |
| METHOD FOR PREDICTING ADVERSE CARDIOVASCULAR EVENTS FOR A PERIOD OF 12 MONTHS IN PATIENTS WITH CHRONIC HEART FAILURE WITH RECURRENCE OF ANGINA AFTER MYOCARDIAL REVASCULARIZATION | 2018 |
|
RU2677611C1 |
| METHOD FOR INDUCTION OF EXTRACARDIAL MYOCARDIAL REVASCULARIZATION IN PATIENTS WITH CORONARY HEART DISEASE | 2021 |
|
RU2758024C1 |
| A METHOD FOR DIAGNOSING HEART FAILURE WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION IN PATIENTS WITH CORONARY ARTERY DISEASE ON THE BACKGROUND OF NON-OCCLUSIVE ATHEROSCLEROSIS OF THE CORONARY ARTERIES | 2022 |
|
RU2789429C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING REPEATED REMODELING OF THE LEFT VENTRICULAR MYOCARDIUM WITHIN 12 MONTHS AFTER SURGICAL TREATMENT OF ISCHEMIC CARDIOMYOPATHY | 2020 |
|
RU2745473C1 |
| METHOD FOR DETERMINING INDICATIONS TO SURGICAL TREATMENT OF CARDIAC ISCHEMIA PATIENTS SURVIVED AFTER MYOCARDIAL INFARCTION | 2004 |
|
RU2269934C1 |
| METHOD OF TREATING ACUTE MYOCARDIAL INFARCTION | 2018 |
|
RU2702146C1 |
| METHOD FOR PREPARING PULMONARY CIRCULATION OF RECIPIENTS BEFORE PERFORMING HEART TRANSPLATION | 2017 |
|
RU2678686C1 |
